Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Wijermans

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|September 21, 1996
[Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera]M E Tesselaar, P W Wijermans, J A Metsaars, et al.
Leukemia Research|January 1, 1989
Maturation induction in freshly isolated human myeloid leukemic cells, 1.25 (OH)2 vitamin D3 being the most potent inducerG J Ossenkoppele, P W Wijermans, J J Nauta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Low-dose cytarabine for acute myeloid leukaemia and myelodysplastic syndromes: in vivo and in vitro cytotoxicityG J Ossenkoppele, P W Wijermans, J J Nauta, et al.
Acta Haematologica|January 1, 1992
Hyaline-vascular type Castleman's disease with concomitant malignant B-cell lymphomaL Buijs, P W Wijermans, K van Groningen, et al.
European Journal of Haematology|August 1, 1991
Coexistence of myelofibrosis and focal osteolysis with clusters of megakaryocytes and necrosis in a patient with trilineage myelodysplastic syndromeV I Rebel, P C Huijgens, P W Wijermans, et al.
The Netherlands Journal of Medicine|October 1, 1989
Standard induction and low dose ara-C treatment in patients over 60 with AML or MDSB M van Geel, P C Huijgens, G J Ossenkoppele, et al.
Clinical and Laboratory Haematology|January 1, 1990
Purification of human megakaryocytes using a glycoprotein Ib dependent agglutination techniqueE C van Pampus, P C Huijgens, P W Wijermans, et al.
The Netherlands Journal of Medicine|October 24, 2007
Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the NetherlandsB A P Laros-van Gorkom, C A M Huisman, P W Wijermans, et al.
Leukemia Research|September 21, 2007
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)P W Wijermans, B Rüter, M R Baer, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 9, 1998
[The risk of a multiple myeloma in patients with paraproteinemia: a myeloma risk score developed in the region of the Comprehensive Cancer Center West]C G Schaar, F Ong, S Snijder, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Nederlands Tijdschrift Voor Geneeskunde|September 21, 1996
[Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera]M E Tesselaar, P W Wijermans, J A Metsaars, et al.
Leukemia Research|January 1, 1989
Maturation induction in freshly isolated human myeloid leukemic cells, 1.25 (OH)2 vitamin D3 being the most potent inducerG J Ossenkoppele, P W Wijermans, J J Nauta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Low-dose cytarabine for acute myeloid leukaemia and myelodysplastic syndromes: in vivo and in vitro cytotoxicityG J Ossenkoppele, P W Wijermans, J J Nauta, et al.
Acta Haematologica|January 1, 1992
Hyaline-vascular type Castleman's disease with concomitant malignant B-cell lymphomaL Buijs, P W Wijermans, K van Groningen, et al.
European Journal of Haematology|August 1, 1991
Coexistence of myelofibrosis and focal osteolysis with clusters of megakaryocytes and necrosis in a patient with trilineage myelodysplastic syndromeV I Rebel, P C Huijgens, P W Wijermans, et al.
The Netherlands Journal of Medicine|October 1, 1989
Standard induction and low dose ara-C treatment in patients over 60 with AML or MDSB M van Geel, P C Huijgens, G J Ossenkoppele, et al.
Clinical and Laboratory Haematology|January 1, 1990
Purification of human megakaryocytes using a glycoprotein Ib dependent agglutination techniqueE C van Pampus, P C Huijgens, P W Wijermans, et al.
The Netherlands Journal of Medicine|October 24, 2007
Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the NetherlandsB A P Laros-van Gorkom, C A M Huisman, P W Wijermans, et al.
Leukemia Research|September 21, 2007
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)P W Wijermans, B Rüter, M R Baer, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 9, 1998
[The risk of a multiple myeloma in patients with paraproteinemia: a myeloma risk score developed in the region of the Comprehensive Cancer Center West]C G Schaar, F Ong, S Snijder, et al.
Pageof 9